DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage: The DxA 5000 is a high-speed, modular, automated sample handling system that performs pre-analytical and post-analytical sample processing and storage. The automation system also sorts, routes, and presents sample tubes to analyzers for analysis. The DxA 5000 also consolidates a variety of analytical instruments, such as an Immunoassay analyzer, into a unified workstation on a track system.
Publicado el 30 de septiembre de 2020 · Inicio del retiro: 17 de junio de 2020
Resumen
FDA registra el retiro Z-2983-2020 de dispositivos médicos de Clase II, publicado el 30 de septiembre de 2020 e iniciado el 17 de junio de 2020. Empresa responsable: Beckman Coulter Biomedical GmbH; Estado: Finalizado; Cantidad reportada: 32 units; Lote: Serial/Lot Number(s)/Software Version: all. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The DxA 5000 instructions for use may be confusing regarding the re-use of sample IDs. Beckman Coulter has received complaints where the re-use of sample barcodes were not being detected by the system .
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Beckman Coulter Biomedical GmbH
- Distribuidor
- Worldwide distribution - US Nationwide distribution including in the states of Illinois, Ohio, Pennsylvania, and West Virginia. The countries of Australia, Canada, China, Czech Republic, France, Israel, Italy, Germany, Switzerland, Spain, Netherlands, and United Kingdom.
- Lote
- Serial/Lot Number(s)/Software Version: all
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Germany
Retiros relacionados
- FDAREMISOL Advance with Software Version 2.5 UDI-DI code: 15099590802073 The Normand Info REMISOL Advance Data12 de agosto de 2026
- FDAPE Centrifuge Temperature Controlled, REF: B36366, a component of the Power Express.11 de septiembre de 2024
- FDAPower Express, REF B9091811 de septiembre de 2024
- FDAPE Centrifuge, REF: B36365, a component of the Power Express11 de septiembre de 2024
- FDAPROFEMUR Neck Long Titanium, Catalog Numbers: PHA01204, PHA01214, PHA01224, PHA01234, PHA01244, PHA01254,30 de septiembre de 2020
- FDAPerceval Single Use Accessory Kit, Size M, REF: ICV1346, Sterile EO, Rx Only, CE, UDI: 8022057015228 - Product30 de septiembre de 2020
Preguntas sobre este retiro
¿DxA 5000; Catalog Number:B50516; UDI:15099590707118 - Product Usage: The DxA 5000 is a high-speed, modular, automated sample handling system that performs pre-analytical and post-analytical sample processing and storage. The automation system also sorts, routes, and presents sample tubes to analyzers for analysis. The DxA 5000 also consolidates a variety of analytical instruments, such as an Immunoassay analyzer, into a unified workstation on a track system. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2983-2020 el 30 de septiembre de 2020. Peligro reportado: The DxA 5000 instructions for use may be confusing regarding the re-use of sample IDs. Beckman Coulter has received complaints where the re-use of sample barcodes were not being detected by the system .
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter